Abstract
To investigate whether further, diagnostic procedures should be recommended in patients with slight increase of preoperative serum basal calcitonin (bCT) levels in whom surgical treatment can be recommendable. Fourteen consecutive patients with nodular thyroid disease underwent thyroidectomy in our center for suspected medullary thyroid microcarcinoma (MTC) because their serum bCT levels were slightly higher than the upper limit of normal range. Serum bCT was measured by radioimmunoassay, normality range = 0–20 ng/L. Surgical specimens were examined by the same pathologist using histologic and immunohistochemistry techniques. An extensive search for parafollicular C-cell hyperplasia (CCH) and/or microscopic MTC foci was performed. At preoperative ultrasound, a single thyroid nodule was depicted in three patients while a multinodular goiter in 11. The bCT values ranged between 24.4 and 94.6 ng/L, median 42.2 ng/L while the pentagastrin-stimulated CT (sCT) values by pentagastrin test ranged between 61.5 and 1,262 ng/L, median 245.0 ng/L. Total thyroidectomy was performed in 13 patients, and lobectomy in the other one; central node dissection was also performed in eight cases. At histology, MTC was diagnosed in nine patients (64.3 %), showing a median maximum diameter of 6.1 mm (range, 1.5–17 mm); CCH was diagnosed in the other five patients (35.7 %). The pentagastrin stimulation test was obtained in all patients. It is worth noting that a very high increase of sCT >100 ng/mL was observed in 5/9 patients with MTC and in 2/4 patients with HCC, therefore suggesting the absence of a relationship between the entity of response to pentagastrin test with a specific pathology (MTC vs. HCC). In six patients, the MTC was the nodule on which preoperative FNAC had been performed, while in other three patients preoperative FNAC had been performed on a different nodule from the MTC. Based on our experience, in case of the pentagastrin stimulation test with sCT <100 ng/L and a single nodule, the CT assay on FNAC may be useful, subsequently lobectomy with definitive histological diagnosis is recommended. In case of the Pg test with sCT <100 ng/L and bilateral goiter, total thyroidectomy with histological diagnosis is recommended. In this way, as for the surgical procedure, total thyroidectomy is recommended in cases of bilateral goiter, while lobectomy can be offered for cases with single nodes with serum dosage of bCT in the strict follow up. In case of the pentagastrin stimulating test with sCT <100 ng/L and bilateral goiter, total thyroidectomy with histological diagnosis is recommended.
Similar content being viewed by others
References
G. Karanikas, A. Moameni, C. Poetzi, G. Zetting, K. Kaserer, C. Bieglmayer et al., Frequency and relevance of elevated calcitonin levels in patients with nonneoplastic thyroid disease and in healthy subjects. J. Clin. Endocrinol. Metab. 89, 515–519 (2004)
R. Seth, P. Motte, A. Kehely, S.J. Wimalawansa, C.H. Self, D. Bellet et al., Sensitive and specific two site enzyme immunoassay for human calcitonin using monoclonal antibodies. J. Endocrinol. 119, 351–357 (1998)
N. Barbot, C. Calmettes, I. Schuffenecker, J.P. Saint Andre, B. Franc, V. Rohmer et al., Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 78, 114–120 (1994)
J.F. Henry, A. Denizot, M. Puccini, L. Gramatica, A. Kvachenyuk, B. Conte Devolx et al., Latent subclinical medullary thyroid carcinoma: diagnosis and treatment. World J. Surg. 22, 727–752 (1998)
F. Pacini, M. Fontanelli, L. Fugazzola, R. Elisei, C. Romei, G. Di Cosia et al., Routine measurement of serum calcitonin in nodular thyroid disease allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 78, 826 (1994)
M. Rieu, M.C. Lame, A. Richard, B. Lissak, B. Sambort, P. Vuong Ngoc et al., Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf.) 42, 453 (1995)
L.M. Thienpont, K. Van Uyfanghe, S. Van Houce, IFCC working group for standardization of thyroid function tests (WG_STFT): standardization activitiesb in the field of thyroid function tests: a status repoprt. Clin. Chem. Lab. Med. 48, 1577–1583 (2010)
P. Doyle, C. Duren, K. Nerlich, F.A. Verburg, I. Grelle, H. Jahn et al., Potency and tolerance of calcitonin stimulation with high dose calcium versus pentagastrin in normal adults. J. Clin. Endocrinol. Metab. 94, 2970–2974 (2009)
T. Rink, P.N. Truong, H.J. Schorth, J. Diener, M. Zinny, J. Diener et al., Calculation and validation of a plasma calcitonin limitfor early detection of medullary thyroid carcinoma in nodular disease. Thyroid 19, 327–332 (2009)
M. d’Herbomez, P. Caron, C. Bauster, C. Do Cao, J.L. Schlienger, R. Sapin et al., Reference range of serum calcitonin levels in humans: influence of calcitonin assay, sex, age and cigarette smoking. Eur. J. Endocrinol. 157, 749–755 (2007)
C. Colombo, U. Verga, C. Mian, S. Ferrero, M. Perrino, L. Vicentini et al., Comparison of calcium and pentagastrin for the diagnosis and follow up of medullary thyroid cancer. J. Clin. Endocrinol. Metab. 97, 905–913 (2012)
R.T. Kloos, C. Eng, D.B. Evans, G.L. Francis, H. Gharib, J.F. Moley et al., Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19, 565–612 (2009)
G. Pina, S. Dubois, A. Murat, N. Berger, P. Niccoli, J.L. Peix et al., Is basal ultrasensitive of calcitonin capable of substituting for the pentagastrin-stimulation test? Clin Endocrinol (Oxf) 78, 358–364 (2013)
E.M. Santos, J.F. Paula, P.M. Motta, M.B. Heinemann, R.C. Leite, J.P. Haddad et al., Comparison of three methods of DNA extraction from peripheral blood mononuclear cells and lung fragments of equines. Genet. Mol. Res. 9, 1591–1598 (2010)
M.R. Pelizzo, I.M. Boschin, S. Barollo, G. Pennelli, A. Toniato, L. Zambonin et al., BRAF analisis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Clin. Chem. Lab. Med. 49, 325–329 (2011)
U. Verga, S. Ferrero, L. Vincentini, T. Brambilla, V. Cirello, M. Muzza et al., Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocr. Relat. Cancer 14, 393–403 (2007)
C. Scheuba, K. Kaserer, A. Moritz, R. Drosten, H. Vierhapper, C. Bieglmayer et al., Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr. Relat. Cancer 16, 243–253 (2009)
R. Elisei, V. Bottici, F. Lucchetti, G. Di Coscio, C. Romei, L. Grasso et al., Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J. Clin. Endocrinol. Metab. 89, 163–168 (2004)
Z. Baloch, P. Carayon, B. Conte-Devolx, L.M. Demers, U. Feldt-Rasmussen, J.F. Henry et al., Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13, 3–126 (2003)
Conflict of interest
The authors have no conflict of interest with the present paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boschin, I.M., Torresan, F., Toniato, A. et al. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine 45, 448–453 (2014). https://doi.org/10.1007/s12020-013-0019-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0019-7